HQL

abrdn Life Sciences Investors
HQL

Overview Fund Activity

49 hedge funds and large institutions have $57.5M invested in abrdn Life Sciences Investors in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.

Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
1.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
20
Reduced
12
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$12.8M
2
First Trust Advisors
2
First Trust Advisors
Illinois
$1.33M
3
VKH
3
Virtu KCG Holdings
New York
$925K
4
DA
4
Doliver Advisors
Texas
$590K
5
GC
5
Guggenheim Capital
Illinois
$587K

Top Sellers

1
SIA
1
Sit Investment Associates
Minnesota
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$650K
3
YCM
3
Yakira Capital Management
Connecticut
$3.38M
4
WAM
4
Weiss Asset Management
Massachusetts
$0
5
CS
5
Credit Suisse
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
51
TFS Capital
Pennsylvania
– -$1.6M -77,090 Closed
RJA
52
Raymond James & Associates
Florida
– -$796K -38,353 Closed
COLIM
53
City of London Investment Management
United Kingdom
– -$492K -23,670 Closed
KIM
54
Karpus Investment Management
New York
– -$363K -17,500 Closed
CCG
55
Cypress Capital Group
Florida
– -$252K -12,140 Closed
TRCT
56
Tower Research Capital (TRC)
New York
– -$47K -2,285 Closed
NSIM
57
North Star Investment Management
Illinois
– -$21K -1,010 Closed
CBT
58
Central Bank & Trust
Kentucky
– -$14K -684 Closed
MSFP
59
Mark Sheptoff Financial Planning
Connecticut
– -$10K -465 Closed
1 2
3